Fatemeh Yarmohammadi

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 17

Top Topics

Endoplasmic Reticulum

Top Venues

Cardiovascular toxicology

Naunyn-Schmiedeberg's archives of pharmacology

Journal of biochemical and molecular toxicology

Human & experimental toxicology

This page only lists publications with an associated author ORCID identifier.

Publications

Habibeh Mashayekhi-Sardoo, Ramin Rezaee, Fatemeh Yarmohammadi, Gholamreza Karimi
Targeting Endoplasmic Reticulum Stress by Natural and Chemical Compounds Ameliorates Cisplatin-Induced Nephrotoxicity: A Review. Biological trace element research (2024)
Mahvash Hesari, Pantea Mohammadi, Mojtaba Moradi, Dareuosh Shackebaei, Fatemeh Yarmohammadi
Molecular mechanisms involved in therapeutic effects of natural compounds against cisplatin-induced cardiotoxicity: a review. Naunyn-Schmiedeberg's archives of pharmacology (2024)
Dareuosh Shackebaei, Mahvash Hesari, Sara Gorgani, Zeinab Vafaeipour, Sanaz Salaramoli, Fatemeh Yarmohammadi
The Role of mTOR in the Doxorubicin-Induced Cardiotoxicity: A Systematic Review. Cell biochemistry and biophysics (2024)
Fatemeh Yarmohammadi, A Wallace Hayes, Gholamreza Karimi
Research trends of computational toxicology: a bibliometric analysis. Toxicology research 13 (5) (2024)
Fatemeh Yarmohammadi, Mahvash Hesari, Dareuosh Shackebaei
The Role of mTOR in Doxorubicin-Altered Cardiac Metabolism: A Promising Therapeutic Target of Natural Compounds. Cardiovascular toxicology (2023)
Fatemeh Yarmohammadi, A Wallace Hayes, Gholamreza Karimi
Molecular mechanisms involved in doxorubicin-induced cardiotoxicity: A bibliometrics analysis by VOSviewer. Naunyn-Schmiedeberg's archives of pharmacology (2023)
Fatemeh Yarmohammadi, Mahvash Hesari, Dareuosh Shackebaei
The Role of mTOR in Doxorubicin-Altered Cardiac Metabolism: A Promising Therapeutic Target of Natural Compounds. Cardiovascular toxicology 24 (2) (2023)
Fatemeh Yarmohammadi, Mahvash Hesari, Dareuosh Shackebaei
The Role of mTOR in Doxorubicin-Altered Cardiac Metabolism: A Promising Therapeutic Target of Natural Compounds. Cardiovascular toxicology 24 (2) (2023)
Fatemeh Yarmohammadi, Mahvash Hesari, Dareuosh Shackebaei
The Role of mTOR in Doxorubicin-Altered Cardiac Metabolism: A Promising Therapeutic Target of Natural Compounds. Cardiovascular toxicology 24 (2) (2023)
Fatemeh Yarmohammadi, Zainab Ebrahimian, Gholamreza Karimi
MicroRNAs target the PI3K/Akt/p53 and the Sirt1/Nrf2 signaling pathways in doxorubicin-induced cardiotoxicity. Journal of biochemical and molecular toxicology (2022)
Fatemeh Yarmohammadi, A Wallace Hayes, Gholamreza Karimi
The therapeutic effects of berberine against different diseases: A review on the involvement of the endoplasmic reticulum stress. Phytotherapy research : PTR 36 (8) (2022)
Fatemeh Yarmohammadi, A Wallace Hayes, Gholamreza Karimi
Targeting PPARs Signaling Pathways in Cardiotoxicity by Natural Compounds. Cardiovascular toxicology 22 (4) (2022)
Fatemeh Yarmohammadi, Hedyieh Karbasforooshan, A Wallace Hayes, Gholamreza Karimi
Inflammation suppression in doxorubicin-induced cardiotoxicity: natural compounds as therapeutic options. Naunyn-Schmiedeberg's archives of pharmacology 394 (10) (2021)
Fatemeh Yarmohammadi, A Wallace Hayes, Gholamreza Karimi
Possible protective effect of resolvin D1 on inflammation in atrial fibrillation: involvement of ER stress mediated the NLRP3 inflammasome pathway. Naunyn-Schmiedeberg's archives of pharmacology 394 (8) (2021)
Fatemeh B Tabrizi, Fatemeh Yarmohammadi, A Wallace Hayes, Gholamreza Karimi
The modulation of SIRT1 and SIRT3 by natural compounds as a therapeutic target in doxorubicin-induced cardiotoxicity: A review. Journal of biochemical and molecular toxicology (2021)
Fatemeh Yarmohammadi, A Wallace Hayes, Gholamreza Karimi
The role of ferroptosis in organ toxicity. Human & experimental toxicology 40 (12_suppl) (2021)
Fatemeh Yarmohammadi, A Wallace Hayes, Gholamreza Karimi
Protective effects of curcumin on chemical and drug-induced cardiotoxicity: a review. Naunyn-Schmiedeberg's archives of pharmacology 394 (7) (2021)